269 related articles for article (PubMed ID: 24445091)
1. Is there a need for MRI within 24 hours after CT-guided percutaneous thermoablation of the liver?
Ringe KI; Wacker F; Raatschen HJ
Acta Radiol; 2015 Jan; 56(1):10-7. PubMed ID: 24445091
[TBL] [Abstract][Full Text] [Related]
2. Image-guided radiofrequency ablation of hepatocellular carcinoma (HCC): is MR guidance more effective than CT guidance?
Clasen S; Rempp H; Hoffmann R; Graf H; Pereira PL; Claussen CD
Eur J Radiol; 2014 Jan; 83(1):111-6. PubMed ID: 24161781
[TBL] [Abstract][Full Text] [Related]
3. Assessment of ablative margin by unenhanced magnetic resonance imaging after radiofrequency ablation for hepatocellular carcinoma.
Koda M; Tokunaga S; Miyoshi K; Kishina M; Fujise Y; Kato J; Matono T; Okamoto K; Murawaki Y; Kakite S
Eur J Radiol; 2012 Oct; 81(10):2730-6. PubMed ID: 22137612
[TBL] [Abstract][Full Text] [Related]
4. Comparison of computed tomography versus magnetic resonance imaging in assessing radiofrequency ablation margins after radiofrequency ablation in patients with hepatocellular carcinomas.
Qu JR; Liu CC; Zhang HK; Li X; Zhang JW; Luo JP; Shao NN; Zhang SN; Li YL; Li HL
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2012 Oct; 34(5):480-5. PubMed ID: 23134824
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic performance of contrast-enhanced computed tomography in the immediate assessment of radiofrequency ablation success in colorectal liver metastases.
Schraml C; Clasen S; Schwenzer NF; Koenigsrainer I; Herberts T; Claussen CD; Pereira PL
Abdom Imaging; 2008; 33(6):643-51. PubMed ID: 18175165
[TBL] [Abstract][Full Text] [Related]
6. Percutaneous radiofrequency ablation of malignant liver tumors with ultrasound and CT fusion imaging guidance.
Xu ZF; Xie XY; Kuang M; Liu GJ; Chen LD; Zheng YL; Lu MD
J Clin Ultrasound; 2014; 42(6):321-30. PubMed ID: 24615771
[TBL] [Abstract][Full Text] [Related]
7. Percutaneous radiofrequency thermoablation as an alternative to surgery for treatment of liver tumour recurrence after hepatectomy.
Elias D; De Baere T; Smayra T; Ouellet JF; Roche A; Lasser P
Br J Surg; 2002 Jun; 89(6):752-6. PubMed ID: 12027986
[TBL] [Abstract][Full Text] [Related]
8. [Efficacy of radiofrequency ablation to treat advanced hepatocellular carcinoma].
Wu J; Chen MH; Yang W; Wu W; Yan K
Zhonghua Gan Zang Bing Za Zhi; 2012 Apr; 20(4):256-60. PubMed ID: 22964144
[TBL] [Abstract][Full Text] [Related]
9. Percutaneous imaging-guided cryoablation of liver tumors: predicting local progression on 24-hour MRI.
Shyn PB; Mauri G; Alencar RO; Tatli S; Shah SH; Morrison PR; Catalano PJ; Silverman SG
AJR Am J Roentgenol; 2014 Aug; 203(2):W181-91. PubMed ID: 24555531
[TBL] [Abstract][Full Text] [Related]
10. Intraoperative magnetic resonance imaging ablation of hepatic tumors.
Martin RC
Am J Surg; 2005 Apr; 189(4):388-94. PubMed ID: 15820448
[TBL] [Abstract][Full Text] [Related]
11. Comparison of gadoxetic acid-enhanced MR imaging versus four-phase multi-detector row computed tomography in assessing tumor regression after radiofrequency ablation in subjects with hepatocellular carcinomas.
Yoon JH; Lee EJ; Cha SS; Han SS; Choi SJ; Juhn JR; Kim MH; Lee YJ; Park SJ
J Vasc Interv Radiol; 2010 Mar; 21(3):348-56. PubMed ID: 20116285
[TBL] [Abstract][Full Text] [Related]
12. MRI assessment of percutaneous ablation of liver tumors: value of subtraction images.
Tatli S; Acar M; Tuncali K; Sadow CA; Morrison PR; Silverman SG
J Magn Reson Imaging; 2013 Feb; 37(2):407-13. PubMed ID: 23023832
[TBL] [Abstract][Full Text] [Related]
13. Radiofrequency ablation of hepatocellular carcinoma: predicting success using contrast-enhanced sonography.
Dill-Macky MJ; Asch M; Burns P; Wilson S
AJR Am J Roentgenol; 2006 May; 186(5 Suppl):S287-95. PubMed ID: 16632690
[TBL] [Abstract][Full Text] [Related]
14. Hepatic radiofrequency under CT-fluoroscopy guidance.
Laganà D; Carrafiello G; Mangini M; Lumia D; Mocciardini L; Chini C; Pinotti G; Cuffari S; Fugazzola C
Radiol Med; 2008 Feb; 113(1):87-100. PubMed ID: 18338130
[TBL] [Abstract][Full Text] [Related]
15. Feasibility, efficacy, and safety of percutaneous MR-guided ablation of small (≤12 mm) hepatic malignancies.
Weiss J; Hoffmann R; Rempp H; Keβler DE; Pereira PL; Nikolaou K; Clasen S
J Magn Reson Imaging; 2019 Feb; 49(2):374-381. PubMed ID: 30221797
[TBL] [Abstract][Full Text] [Related]
16. Unresectable colorectal liver metastases: percutaneous ablation using CT-guided high-dose-rate brachytherapy (CT-HDBRT).
Collettini F; Lutter A; Schnapauff D; Hildebrandt B; Puhl G; Denecke T; Wust P; Gebauer B
Rofo; 2014 Jun; 186(6):606-12. PubMed ID: 24407711
[TBL] [Abstract][Full Text] [Related]
17. Recurrence-free survival after radiofrequency ablation of hepatocellular carcinoma. A registry report of the impact of risk factors on outcome.
Zytoon AA; Ishii H; Murakami K; El-Kholy MR; Furuse J; El-Dorry A; El-Malah A
Jpn J Clin Oncol; 2007 Sep; 37(9):658-72. PubMed ID: 17766723
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of contrast-enhanced US versus CT or MRI for the therapeutic control of percutaneous radiofrequency ablation in the case of hepatic malignancies.
Frieser M; Kiesel J; Lindner A; Bernatik T; Haensler JM; Janka R; Hahn EG; Strobel D
Ultraschall Med; 2011 Apr; 32(2):148-53. PubMed ID: 21225567
[TBL] [Abstract][Full Text] [Related]
19. Radiofrequency ablation of hepatocellular carcinoma: treatment success as defined by histologic examination of the explanted liver.
Lu DS; Yu NC; Raman SS; Limanond P; Lassman C; Murray K; Tong MJ; Amado RG; Busuttil RW
Radiology; 2005 Mar; 234(3):954-60. PubMed ID: 15681691
[TBL] [Abstract][Full Text] [Related]
20. MRI and CT characteristics of successfully ablated renal masses: Imaging surveillance after radiofrequency ablation.
Davenport MS; Caoili EM; Cohan RH; Ellis JH; Higgins EJ; Willatt J; Fox GA
AJR Am J Roentgenol; 2009 Jun; 192(6):1571-8. PubMed ID: 19457820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
